<DOC>
	<DOCNO>NCT02801630</DOCNO>
	<brief_summary>This double blind randomize control trial Surface Acoustic Wave Patch device treatment Trigeminal Neuralgia . This crossover study group receive sham device . Subjects monitor subjective criterion pain quality life , well objective measurement analgesic usage .</brief_summary>
	<brief_title>An Evaluation Effect Surface Acoustic Wave Patch Device Symptons Trigeminal Neuralgia</brief_title>
	<detailed_description>This study double blind randomize control trial Surface acoustic wave patch device treatment Trigeminal Neuralgia . All subject enrol 14 day lead period , baseline measure pain , quality life analgesic use record . During first month study subject randomize sham active device group . Both group assess every two week pain , quality life analgesic use . After 4 week , subject sham group cross active group . Both group continue assessed biweekly month 2 3 . After 3 month treatment final assessment conduct result evaluate .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Trigeminal Neuralgia</mesh_term>
	<criteria>Participant willing able give inform consent participation study . Male Female , age 18 year . Diagnosed trigeminal neuralgia refractory medical treatment ( modify BNI V ) . Male female , age 18 . Active illicit drug use Pregnancy . Psychiatric illness may prevent patient participation study . Anesthesia dolorosa pain great equal 3/10 Dental implant . Other known pathology trigeminal nerve include iatrogenic anesthesia dolorosa . Cancer bone metastasis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>